Price
$115.67+23.49%Social Signal Score
Analyst Ratings
15 analystsRevenue
$118.38M+3627.20%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Emily Marine Leproust
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 979
- Beta
- 2.22
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- 28.47
Financials
Revenue
$118.38M+3627.2%Net Income
$-35.05MEBITDA
$-27.96MFree Cash Flow
$-8.55MEPS (diluted)
$-0.56Shares Outstanding (diluted)
62.40M+232.3%Operating Expenses
$98.73MCash & Debt
$166.84MReturn of Capital
$6.0KRevenue by Segment (annual)
$376.57MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $376.57M | $-77.67M | $-1.30 |
| 2024 | $312.97M | $-208.73M | $-3.60 |
| 2023 | $245.11M | $-204.62M | $-3.60 |
| 2022 | $203.56M | $-217.86M | $-4.04 |
| 2021 | $132.33M | $-152.10M | $-3.15 |
| 2020 | $90.10M | $-139.93M | $-3.57 |
| 2019 | $54.38M | $-107.67M | $-3.92 |
| 2018 | $25.43M | $-71.24M | $-2.68 |
| 2017 | $10.77M | $-59.31M | $-3.16 |
| 2016 | $2.27M | $-44.09M | $-2.35 |
Valuation
TWSThas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
70+40.00%Social Signal Score
Mentions (18)
- News (RSS)seekingalpha·7d ago·Positive
Twist Bioscience: Don't Confuse A Short Squeeze With An AI Revolution
View source ↗ - Newsbenzinga.com·10d ago·Neutral
Twist Bioscience Stock Hits New High, Then Retreats: What's Happening? Twist Bioscience Corp. (NASDAQ:TWST) shares are trading lower Friday, pulling back after touching a fresh 52-week high near $192 earlier in the session. Here's what you should know.
View source ↗ - News (RSS)investing·11d ago·Neutral
Twist Bioscience stock hits 52-week high at 170.69 USD
View source ↗ - Newsfool.com·17d ago·Positive
Why Twist Bioscience Stock Skyrocketed This Week The biotech will both contribute to and draw from its findings. It'll also earn revenue from its participation.
View source ↗ - 4chan /biz/biz·18d ago·Positive
My Biotech account is having a good year and that's with me taking out like 20k midyear to buy a boat No options or leverage, stocks only, biggest gainer has been TWST
View source ↗ - News (RSS)investing·19d ago·Neutral
Twist Bioscience stock rises on Eli Lilly partnership deal
View source ↗ - News (RSS)yahoo·19d ago·Neutral
AI and Next-Gen Sequencing Strengthens Twist Bioscience Corp. (TWST)
View source ↗ - Newsbenzinga.com·19d ago·Negative
Beyond Hype: Twist Bioscience Secures Data Pipeline Role In Eli Lilly TuneLab Ecosystem Twist Bioscience Corporation (NASDAQ:TWST) on Wednesday announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Co. (NYSE:LLY).
View source ↗ - 4chan /biz/biz·21d ago·Positive
>>62689779 I’m bullish ai so I bought some biotech companies that would benefit Bought TWST Last year and tripled my money Think of second order effects ai may have and invest there the main stocks are overbought imo
View source ↗ - News (RSS)investing·24d ago·Neutral
Cathie Wood’s ARK sells Twist Bioscience stock, buys more Intellia
View source ↗ - News (RSS)investing·31d ago·Positive
Cathie Wood’s ARK sees major stock moves with Robinhood and Twist Bioscience
View source ↗ - News (RSS)zerohedge·41d ago·Neutral
Markets Now Face Two Wars And Two Economic Wars Markets Now Face Two Wars And Two Economic Wars By Michael Every of Rabobank Two wars and two economic wars Friday’s Jackson Hole speech from Fed Chair Warsh would traditionally be the big event this week but that’s arguably no longer true: the action is not with central banks but elsewhere. I don’t mean the ECB’s Lagarde going to work for the WEF. Rather, markets now face two wars and two economic wars. Dawn in the US will see what Treasury Secret
View source ↗ - News (RSS)seekingalpha·43d ago·Neutral
Notable healthcare headlines for the week: Moderna, Merck, and Twist Bioscience in focus
View source ↗ - News (RSS)seekingalpha·46d ago·Positive
Twist Biosciences: AI-Driven Rally Or Short Squeeze? I'm Neutral (For Now)
View source ↗ - Newsseekingalpha.com·46d ago·Neutral
…tral (For Now) Twist Bioscience Corporation is rated Hold, as its $9.5bn valuation appears disconnected from current fundamentals, and profitability remains elusive. TWST's recent 200% stock surge is driven by AI-related news, short squeeze dynamics, and strong DSPS revenue growth, not by blowout earnings. Full-year 2026 guidance was raised to $456–$457m revenue with adjusted EBITDA breakeven targeted, but losses and elevated SG&A persist.
View source ↗ - 4chan /biz/biz·47d ago·Neutral
I am making it big today in Biotech, but not from Moderna, but from TWST
View source ↗ - News (RSS)latimes·53d ago·Negative
Twist cap maker announces layoffs as California's wine industry struggles G3 Enterprises, which makes wine corks and bottles, announced plans to lay off 66 workers, in yet another hit to California's wine industry
View source ↗ - 4chan /biz/biz·59d ago·Neutral
>>62573885 The biggest one is TWST which I bought for $30 last October
View source ↗
Earnings
Fri, Nov 13(in 5 weeks)
Consensus estimate $-0.44 per share
Typical surprise -4.2% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 3$-0.56 vs $-0.51miss
- Mon, May 4$-0.71 vs $-0.49miss
- Mon, Feb 2$-0.50 vs $-0.48miss
- Fri, Nov 14$-0.45 vs $-0.50beat
- Mon, Aug 4$-0.47 vs $-0.54beat
- Mon, May 5$-0.66 vs $-0.56miss
Estimates and results for TWST via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by TWST officers and directors.
- Bought
- —
- Sold
- $108.1m
0 trades
82 trades
- Leproust Emily M.sold
- Leproust Emily M.sold
- Leproust Emily M.sold
- Leproust Emily M.sold
- Leproust Emily M.sold
- Leproust Emily M.sold
- Leproust Emily M.sold
- Leproust Emily M.sold
18 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Dwight Evanshouse · PA03 · disclosed Apr 23, 2020 (52d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.